# INNOVATE BIOPHARMACEUTICLS I (INNTWXXXX)

> Institutional ownership reported to the SEC as of Q1 2020, from Form 13F filings. Source: https://holderbook.com/stocks/INNTWXXXX/

- Reporting holders: 2
- Reported value: $52.0K
- Held through calls: 84.6%
- Held through puts: 15.4%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GROUP ONE TRADING, L.P.](https://holderbook.com/funds/932540-group-one-trading-l-p/) | $34.0K | 0 | 0.0% | 1 |
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $18.0K | 0 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2020 | 2 | $52.0K |
| Q4 2019 | 1 | $8.0K |
| Q3 2019 | 2 | $10.0K |
| Q2 2019 | 2 | $16.0K |
| Q1 2019 | 2 | $90.0K |
| Q4 2018 | 2 | $67.0K |